Clinical Trial

Bacillus Cereus Invasive Infections in Preterm Neonates Hospitalized in French Hospitals

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 28, 2026 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Background. Bacillus cereus group (Bc) comprises twenty-six closely related species of spore-forming environmental bacteria. Recently, increased sepsis and septic shock caused by Bc were reported in preterm neonates (PN), and the mortality rate can reach up to 30%. Using Whole Genome Sequencing (WGS) increasingly used to characterize Bc strains, The team aimed to determine an accurate identification to the species level of the strains involved in Bc invasive infections in preterm neonates in France and study their virulome profile.Methods. The team performed WGS for 40 neonate clinical strains responsible for invasive infections in PN. A screening of virulence genes was performed to characterize strains associated with poor prognosis. Clinical data were collected and all clinical and genomic findings were analyzed for risk factors for death. "
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-13.
Status change: Completed → Recruiting 2026-01-27
Trial Details
NCT Number NCT06973174
Lead Sponsor Centre Hospitalier Universitaire de Nice
Conditions Sepsis, Infections
Enrollment 40 participants
Start Date 2010-01-01
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-28